{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:09:28Z","timestamp":1780045768035,"version":"3.53.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chronic hepatitis B virus (HBV) infection continues to pose a significant global disease burden, because of its potential progression to liver cirrhosis and hepatocellular carcinoma (HCC). Worldwide, more than 250 million individuals are estimated to be living with chronic HBV infection\n                      <jats:bold>.<\/jats:bold>\n                      Under standard serologic interpretation, the presence of hepatitis B surface antigen (HBsAg) signifies ongoing infection, whereas antibodies to hepatitis B surface antigen (anti-HBs) are generally associated with viral clearance or protective immunity. The simultaneous presence of both markers is rare and may lead to misinterpretation of serologic results, particularly when identified incidentally during routine screening in\u00a0a primary care settings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We describe a 60-year-old Saudi woman with an asymptomatic chronic HBV infection incidentally identified during routine pre-colonoscopy screening in\u00a0a primary care setting. Laboratory testing revealed reactive HBsAg, total anti-HBc positivity, reactive anti-HBs titer, and HBV DNA level was 275\u00a0IU\/mL consistent with low-level viremia. Liver enzymes were mildly elevated on prior testing subsequently normalized on follow- up. Transient elastography demonstrated no evidence of hepatic fibrosis or steatosis. The patient had no history of HBV vaccination, blood transfusions, liver disease, or recognized high-risk exposures, including intravenous drug use or high-risk sexual or household contact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights a diagnostic pitfall in HBV serology, as concurrent HBsAg and anti-HBs positivity does not indicate viral clearance and may reflect immune escape mutations, viral heterogeneity, or host immune factors. Recognition of this rare serologic profile is particularly important for primary care physicians, as accurate interpretation requires integration of serologic, virologic, and clinical data, particularly in asymptomatic patients identified through routine screening. This\u00a0ensure appropriate diagnosis, long-term surveillance, and risk stratification. Clinicians should remain vigilant when encountering this rare serologic profile to guide appropriate referral and follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-026-06091-y","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:24:10Z","timestamp":1778167450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breaking the serologic rule: chronic hepatitis B with simultaneous HBsAg and anti-HBs positivity\u2014a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9235-7979","authenticated-orcid":false,"given":"Ghada Mohamed","family":"Balah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Salmen","family":"Bazuqamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam Ahmed","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Aly","family":"Moharram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend Masoud","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira Abdelfatah","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ismail","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"10","key":"6091_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"Polaris Observatory Collaborators","year":"2023","unstructured":"Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879\u2013907. https:\/\/doi.org\/10.1016\/S2468-1253(23)00197-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"6091_CR2","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/hep.29800.","journal-title":"Hepatology"},{"issue":"4","key":"6091_CR3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.7150\/ijbss.55724","volume":"17","author":"X Jiang","year":"2021","unstructured":"Jiang X, Chang L, Yan Y, Wang L. Paradoxical HBsAg and anti-HBs coexistence among chronic HBV infections: causes and consequences. Int J Biol Sci. 2021;17(4):1125\u201337. https:\/\/doi.org\/10.7150\/ijbss.55724.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"6091_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/v16050713","volume":"16","author":"MJ Ali","year":"2024","unstructured":"Ali MJ, Shah PA, Rehman KU, Kaur S, Holzmayer V, Cloherty GA, et al. Immune escape mutations are prevalent among patients with a coexistence of HBsAg and anti-HBs in a tertiary liver center in the United States. Viruses. 2024;16(5):713. https:\/\/doi.org\/10.3390\/v16050713.","journal-title":"Viruses"},{"issue":"2","key":"6091_CR5","doi-asserted-by":"publisher","first-page":"e39097","DOI":"10.5812\/hepatmon.39097","volume":"16","author":"R Rezaee","year":"2016","unstructured":"Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, Alavian SM, et al. Impacts of the G145R mutation on the structure and immunogenic activity of the hepatitis B surface antigen: a computational analysis. Hepat Mon. 2016;16(2):e39097. https:\/\/doi.org\/10.5812\/hepatmon.39097.","journal-title":"Hepat Mon"},{"issue":"5","key":"6091_CR6","doi-asserted-by":"publisher","first-page":"e2216485","DOI":"10.1001\/jamanetworkopen.2022.16485","volume":"5","author":"J Wang","year":"2022","unstructured":"Wang J, Ding W, Liu J, et al. Association of coexistent hepatitis B surface antigen and antibody with severe liver fibrosis and cirrhosis in treatment-naive patients with chronic hepatitis B. JAMA Netw Open. 2022;5(5):e2216485. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.16485.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"6091_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bjid.2019.08.007","volume":"23","author":"ZZ Jin","year":"2019","unstructured":"Jin ZZ, Jin FF, Liu X, Liu N, Wen F, Lou JL. Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load. Braz J Infect Dis. 2019;23(5):343\u201351. https:\/\/doi.org\/10.1016\/j.bjid.2019.08.007.","journal-title":"Braz J Infect Dis"},{"issue":"7","key":"6091_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/jvh.13668","volume":"29","author":"DZ Xu","year":"2022","unstructured":"Xu DZ, Yang HC, Liu XY, et al. Coexistence of hepatitis B surface antigen and antibody in patients with chronic hepatitis B virus infection: a systematic review and meta-analysis. J Viral Hepat. 2022;29(7):545\u201355. https:\/\/doi.org\/10.1111\/jvh.13668.","journal-title":"J Viral Hepat"},{"key":"6091_CR9","doi-asserted-by":"publisher","first-page":"199567","DOI":"10.1016\/j.virusres.2025.199567","volume":"355","author":"Z Pu","year":"2025","unstructured":"Pu Z, Zheng X, Liu L, Lin D, Zhang H, Li J, et al. HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases. Virus Res. 2025;355:199567. https:\/\/doi.org\/10.1016\/j.virusres.2025.199567.","journal-title":"Virus Res"},{"key":"6091_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jcv.2014.11.015","volume":"62","author":"M Pancher","year":"2015","unstructured":"Pancher M, D\u00e9sir\u00e9 N, Ngo Y, Akhavan S, Pallier C, Poynard T, et al. Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification. J Clin Virol. 2015;62:32\u20137. https:\/\/doi.org\/10.1016\/j.jcv.2014.11.015.","journal-title":"J Clin Virol"},{"key":"6091_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jmv.23779","volume":"86","author":"SI Seo","year":"2014","unstructured":"Seo SI, Choi HS, Choi BY, Kim HS, Kim HY, Jang MK. Coexistence of Hepatitis B surface antigen and antibody to Hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic Hepatitis B virus infection: a retrospective cohort study. J Med Virol. 2014;86:124\u201330. https:\/\/doi.org\/10.1002\/jmv.23779.","journal-title":"J Med Virol"},{"issue":"3","key":"6091_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4274\/vhd.galenos.2022.2022-6-2","volume":"28","author":"\u00c7M Ayaz","year":"2022","unstructured":"Ayaz \u00c7M, Ba\u015fp\u0131nar B, G\u00fcner R. Atipik Serolojik Profilli Hepatit B Hastalar\u0131n\u0131n Klinik ve Laboratuvar \u00d6zellikleri. Clinical and laboratory characteristics of patients with hepatitis B with atypical serologic profiles. Viral Hepat J. 2022;28(3):94-s99. https:\/\/doi.org\/10.4274\/vhd.galenos.2022.2022-6-2.","journal-title":"Viral Hepat J"},{"key":"6091_CR13","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jvh.13312","volume":"27","author":"WM Lee","year":"2020","unstructured":"Lee WM, King WC, Schwarz KB, Rule J, Lok ASF. Prevalence and clinical features of patients with concurrent HBsAg and anti-HBs: evaluation of the Hepatitis B research network cohort. J Viral Hepat. 2020;27:922\u201331. https:\/\/doi.org\/10.1111\/jvh.13312.","journal-title":"J Viral Hepat"},{"key":"6091_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/jmv.24782","volume":"89","author":"X Fu","year":"2017","unstructured":"Fu X, Chen J, Chen H, Lin J, Xun Z, Li S, et al. Mutation in the S gene of Hepatitis B virus and anti-HBs subtype-non specificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic Hepatitis B virus infection. J Med Virol. 2017;89:1419\u201326. https:\/\/doi.org\/10.1002\/jmv.24782.","journal-title":"J Med Virol"},{"key":"6091_CR15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1086\/513200","volume":"44","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, et al. Coexistence of Hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic Hepatitis B virus infection. Clin Infect Dis. 2007;44:1161\u20139. https:\/\/doi.org\/10.1086\/513200.","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06091-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:24:52Z","timestamp":1780043092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06091-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6091"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06091-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the publication of this case report was obtained from the Institutional Review Board (IRB) of King Khaled Hospital, Ministry of Health, Najran, Saudi Arabia (IRB Approval No.:\n                      [Log Oct 2025-72A]\n                      ). The report was prepared in accordance with institutional guidelines and the principles of the National committee of Bioethics (NCBE). A copy of the written consent is available for review by the Editors of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests regarding the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}